Article Versions Notes

Grigoriou K, Karakasis P, Nasoufidou A, Stachteas P, Klisic A, Karagiannidis E, Fyntanidou B, Popovic DS, Patoulias D, Antoniadis AP, et al. SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era. Medicina. 2025; 61(11):1903. https://doi.org/10.3390/medicina61111903

Grigoriou, Konstantinos, Paschalis Karakasis, Athina Nasoufidou, Panagiotis Stachteas, Aleksandra Klisic, Efstratios Karagiannidis, Barbara Fyntanidou, Djordje S. Popovic, Dimitrios Patoulias, Antonios P. Antoniadis, and et al. 2025. "SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era" Medicina 61, no. 11: 1903. https://doi.org/10.3390/medicina61111903

Grigoriou, K., Karakasis, P., Nasoufidou, A., Stachteas, P., Klisic, A., Karagiannidis, E., Fyntanidou, B., Popovic, D. S., Patoulias, D., Antoniadis, A. P., & Fragakis, N. (2025). SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era. Medicina, 61(11), 1903. https://doi.org/10.3390/medicina61111903